News & Articles

ELRIG appoints Hitesh Sanganee and Marcus Schindler to strengthen scientific leadership in drug discovery

Flagship event will showcase leaders in drug discovery alongside cutting-edge research and innovation

Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets

Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

Leadership team is strengthened to support next phase of growth as organization evolves to meet needs of global drug discovery community

Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

ELRIG appoints Dr. Del Trezise as Chair of the Board

Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15

The partners will host a joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from November 18–19, 2024

On July 3, SelectScience and ELRIG will be hosting an online event showcasing advances in cell-based screening in drug discovery to extend high-quality content to the global audience

Partnership endorses mission to facilitate career progression and support life science industry growth

Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal free drug discovery

Group aims to support start-up businesses while expanding the ELRIG community

ELRIG Drug Discovery 2023 at ACC Liverpool, UK (October 18–19) to focus on diverse thinking and new perspectives

ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community

ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community

Major learned societies initiate two-year strategic alliance

Find out why PROTACs hold such promise in cancer drug discovery

Organoid expert reveals recent developments, benefits, and challenges in organoid research

Determining connections between genetic traits and diseases using genome-wide studies could help improve efficacy and safety of new therapeutic drug

ELRIG organisers explain why they believe sharing and communicating the latest research and advances in technology is key to overcoming challenges in drug discovery